[
  {
    "ts": null,
    "headline": "CVS Health : 2025 CEO and CFO certifications",
    "summary": "Certification I, J. David Joyner, President and Chief Executive Officer of CVS Health Corporation, certify that: 1. I have reviewed...",
    "url": "https://finnhub.io/api/news?id=e3c665ab5b2d06fb40249d3a221e6137c1ba3e5bfa384aa364b82ab270bef53d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743455945,
      "headline": "CVS Health : 2025 CEO and CFO certifications",
      "id": 133630534,
      "image": "",
      "related": "CVS",
      "source": "Finnhub",
      "summary": "Certification I, J. David Joyner, President and Chief Executive Officer of CVS Health Corporation, certify that: 1. I have reviewed...",
      "url": "https://finnhub.io/api/news?id=e3c665ab5b2d06fb40249d3a221e6137c1ba3e5bfa384aa364b82ab270bef53d"
    }
  },
  {
    "ts": null,
    "headline": "CVS Is the S&P 500's Top Performer of the Quarter—Here's Why",
    "summary": "One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year.",
    "url": "https://finnhub.io/api/news?id=2f447afb6e92757abd4322fa19ce040ecb151eb4e21d909c8deb392ae989b2b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743454724,
      "headline": "CVS Is the S&P 500's Top Performer of the Quarter—Here's Why",
      "id": 133633108,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% since the start of the year.",
      "url": "https://finnhub.io/api/news?id=2f447afb6e92757abd4322fa19ce040ecb151eb4e21d909c8deb392ae989b2b0"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Corporation (CVS): Among the Best High Yield Stocks to Buy in April for Dividend Capture",
    "summary": "We recently published a list of Dividend Capture Strategy: 15 High Yield Stocks to Buy in April. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best high yield stocks to buy in April. Dividend investing appears to be a simple strategy on the surface, […]",
    "url": "https://finnhub.io/api/news?id=2fbac41c613e061853ae0d04a77a798eba076f51287f77e85262c13385f6ecf4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743445328,
      "headline": "CVS Health Corporation (CVS): Among the Best High Yield Stocks to Buy in April for Dividend Capture",
      "id": 133633109,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently published a list of Dividend Capture Strategy: 15 High Yield Stocks to Buy in April. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best high yield stocks to buy in April. Dividend investing appears to be a simple strategy on the surface, […]",
      "url": "https://finnhub.io/api/news?id=2fbac41c613e061853ae0d04a77a798eba076f51287f77e85262c13385f6ecf4"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health and Deckers Are the S&P 500’s Best and Worst for the Quarter. Here’s Why.",
    "summary": "The first quarter is in the books, and the  best and worst performers are a pharmacy chain and a footwear company—certainly not the usual suspects.  CVS Health  was the N0.  Conversely,  Deckers Outdoor  did the worst, falling 46%.",
    "url": "https://finnhub.io/api/news?id=239acfef8800bd41a523c5f52b9ba54eb82929953fe3c79dd106e9de9eb45d2e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743439140,
      "headline": "CVS Health and Deckers Are the S&P 500’s Best and Worst for the Quarter. Here’s Why.",
      "id": 133627929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The first quarter is in the books, and the  best and worst performers are a pharmacy chain and a footwear company—certainly not the usual suspects.  CVS Health  was the N0.  Conversely,  Deckers Outdoor  did the worst, falling 46%.",
      "url": "https://finnhub.io/api/news?id=239acfef8800bd41a523c5f52b9ba54eb82929953fe3c79dd106e9de9eb45d2e"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer on CVS Health (CVS): “A Comeback Story with New Management!”",
    "summary": "We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where CVS Health Corporation’s (NYSE:CVS) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on […]",
    "url": "https://finnhub.io/api/news?id=4842d3267d50ce968ad9dd30f1dc401001e4630d3cce028f6d21c4ec4d69a824",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743434027,
      "headline": "Jim Cramer on CVS Health (CVS): “A Comeback Story with New Management!”",
      "id": 133627930,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where CVS Health Corporation’s (NYSE:CVS) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on […]",
      "url": "https://finnhub.io/api/news?id=4842d3267d50ce968ad9dd30f1dc401001e4630d3cce028f6d21c4ec4d69a824"
    }
  },
  {
    "ts": null,
    "headline": "The 3 Best Performing S&P 500 Stocks of 2025 Q1",
    "summary": "Spoiler Alert: No technology stocks made the list. Wait, what?",
    "url": "https://finnhub.io/api/news?id=38e76539761ea51ea3d4e7e219bfec106e3aaedc07d5c936dfc5670e3592f654",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743433200,
      "headline": "The 3 Best Performing S&P 500 Stocks of 2025 Q1",
      "id": 133627811,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Spoiler Alert: No technology stocks made the list. Wait, what?",
      "url": "https://finnhub.io/api/news?id=38e76539761ea51ea3d4e7e219bfec106e3aaedc07d5c936dfc5670e3592f654"
    }
  },
  {
    "ts": null,
    "headline": "Biotech Stocks Q1 2025 Recap: Winners And Underperformers",
    "summary": "Biotech Stocks Q1 2025 Recap: Winners And Underperformers",
    "url": "https://finnhub.io/api/news?id=fca2009a34592e24b4f3882a92027b0a12ab50ad4e5643e6b09744fc6b98a472",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743431649,
      "headline": "Biotech Stocks Q1 2025 Recap: Winners And Underperformers",
      "id": 133628853,
      "image": "",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=fca2009a34592e24b4f3882a92027b0a12ab50ad4e5643e6b09744fc6b98a472"
    }
  },
  {
    "ts": null,
    "headline": "CVS leads S&P 500 in Q1, Deckers & Tesla are biggest losers",
    "summary": "On the final day of the first quarter of 2025, Madison Mills and Julie Hyman take a look at the best and worst-performing stocks and sectors of the year so far. Among the worst performers are Deckers (DECK) and Tesla (TSLA), while CVS Health (CVS) led gains.To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=db8c2d591a10cf1a104893c8e26e5879e56024bf977ad91eef90767e53d7fde1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743429671,
      "headline": "CVS leads S&P 500 in Q1, Deckers & Tesla are biggest losers",
      "id": 133627770,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "On the final day of the first quarter of 2025, Madison Mills and Julie Hyman take a look at the best and worst-performing stocks and sectors of the year so far. Among the worst performers are Deckers (DECK) and Tesla (TSLA), while CVS Health (CVS) led gains.To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=db8c2d591a10cf1a104893c8e26e5879e56024bf977ad91eef90767e53d7fde1"
    }
  },
  {
    "ts": null,
    "headline": "Here’s What Dragged CVS Health Corp. (CVS) in Q4",
    "summary": "Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Hotchkis & Wiley Large Cap Fundamental Value Fund returned – 0.91% in the fourth quarter, outperforming the Russell 1000 Value Index’s -1.98% return. […]",
    "url": "https://finnhub.io/api/news?id=999946d88c08ec64deb99cecf1e0d8ae28e3fb217adf3b341b9cce1527ae3837",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743425076,
      "headline": "Here’s What Dragged CVS Health Corp. (CVS) in Q4",
      "id": 133627933,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Hotchkis & Wiley, an investment management company, released its “Hotchkis & Wiley Large Cap Fundamental Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Hotchkis & Wiley Large Cap Fundamental Value Fund returned – 0.91% in the fourth quarter, outperforming the Russell 1000 Value Index’s -1.98% return. […]",
      "url": "https://finnhub.io/api/news?id=999946d88c08ec64deb99cecf1e0d8ae28e3fb217adf3b341b9cce1527ae3837"
    }
  },
  {
    "ts": null,
    "headline": "The 1-Minute Market Report March 30, 2025",
    "summary": "The market was down 1.5% for the week and down 5.1% YTD. In addition to tariff war worries, weakness in Consumer Spending and Earnings Estimates drove the market lower. Read more here...",
    "url": "https://finnhub.io/api/news?id=ecfe2ff838fe77651a48b527459602298faf00b34fabfd47bd594675ae0df89e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743408300,
      "headline": "The 1-Minute Market Report March 30, 2025",
      "id": 133625541,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159126735/image_2159126735.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "The market was down 1.5% for the week and down 5.1% YTD. In addition to tariff war worries, weakness in Consumer Spending and Earnings Estimates drove the market lower. Read more here...",
      "url": "https://finnhub.io/api/news?id=ecfe2ff838fe77651a48b527459602298faf00b34fabfd47bd594675ae0df89e"
    }
  }
]